Related Experiment Video

Updated: May 17, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Mitosis-targeted anti-cancer therapies: where they stand

K-S Chan1, C-G Koh, H-Y Li

  • 1Division of Molecular and Cell Biology, School of Biological Sciences, College of Science, Nanyang Technological University, Singapore, Singapore.

Cell Death & Disease
|October 19, 2012
PubMed

Insights

Targeting cancer cells during mitosis shows promise, but clinical success faces challenges due to complex biological responses. Further research into mitotic cell death pathways and drug mechanisms is crucial for effective cancer therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Cancer is characterized by cell-cycle deregulation, making mitosis a key target for therapies.
  • Antimitotic drugs exploit the vulnerability of cancerous cells during mitosis, offering selectivity and sensitivity.
  • Despite advancements, clinical success of antimitotic therapies is hindered by unpredictable patient responses.

Purpose of the Study:

  • To review current antimitotic agents and evaluate their clinical efficacy and limitations.
  • To explore the mechanistic pathways of mitotic cell death (MCD).
  • To identify future directions for mitotic anticancer strategies.

Main Methods:

  • Literature review of current antimitotic agents.
  • Evaluation of clinical efficacy and limitations of these agents.
  • Discussion of mechanistic pathways and target validation for MCD.

Main Results:

  • Antimitotic therapies show effectiveness against abnormal cell proliferation but face challenges in clinical translation.
  • Complexities in the human body's response to these drugs limit their success.
  • Existing research highlights the need for further investigation into MCD pathways.

Conclusions:

  • Bridging the gap between preclinical findings and clinical application requires a deeper understanding of MCD.
  • Future strategies should focus on comprehensive target validation and understanding drug-body interactions.
  • Continued research is essential for optimizing antimitotic therapies for cancer treatment.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.